BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22347780)

  • 1. 2 D - QSAR studies on CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]- 1 H-triazoles.
    Yadav M
    Bioinformation; 2011; 7(8):388-92. PubMed ID: 22347780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and CYP26A1 inhibitory activity of 1-[benzofuran-2-yl-(4-alkyl/aryl-phenyl)-methyl]-1H-triazoles.
    Pautus S; Yee SW; Jayne M; Coogan MP; Simons C
    Bioorg Med Chem; 2006 Jun; 14(11):3643-53. PubMed ID: 16458519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents.
    Stoppie P; Borgers M; Borghgraef P; Dillen L; Goossens J; Sanz G; Szel H; Van Hove C; Van Nyen G; Nobels G; Vanden Bossche H; Venet M; Willemsens G; Van Wauwe J
    J Pharmacol Exp Ther; 2000 Apr; 293(1):304-12. PubMed ID: 10734183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.
    Thatcher JE; Buttrick B; Shaffer SA; Shimshoni JA; Goodlett DR; Nelson WL; Isoherranen N
    Mol Pharmacol; 2011 Aug; 80(2):228-39. PubMed ID: 21521770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells.
    Gomaa MS; Armstrong JL; Bobillon B; Veal GJ; Brancale A; Redfern CP; Simons C
    Bioorg Med Chem; 2008 Sep; 16(17):8301-13. PubMed ID: 18722776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eco-friendly synthesis, in vitro anti-proliferative evaluation, and 3D-QSAR analysis of a novel series of monocationic 2-aryl/heteroaryl-substituted 6-(2-imidazolinyl)benzothiazole mesylates.
    Racané L; Ptiček L; Sedić M; Grbčić P; Kraljević Pavelić S; Bertoša B; Sović I; Karminski-Zamola G
    Mol Divers; 2018 Aug; 22(3):723-741. PubMed ID: 29667008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates.
    Gomaa MS; Bridgens CE; Aboraia AS; Veal GJ; Redfern CP; Brancale A; Armstrong JL; Simons C
    J Med Chem; 2011 Apr; 54(8):2778-91. PubMed ID: 21428449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Structure-Activity Relationship Study of Camptothecin Derivatives as Anticancer Drugs Using Molecular Descriptors.
    Ahmadinejad N; Shafiei F
    Comb Chem High Throughput Screen; 2019; 22(6):387-399. PubMed ID: 31284856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26).
    Gomaa MS; Bridgens CE; Veal GJ; Redfern CP; Brancale A; Armstrong JL; Simons C
    J Med Chem; 2011 Oct; 54(19):6803-11. PubMed ID: 21838328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
    Leonard JT; Roy K
    Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
    Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
    Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors.
    Sun B; Liu K; Han J; Zhao LY; Su X; Lin B; Zhao DM; Cheng MS
    Bioorg Med Chem; 2015 Oct; 23(20):6763-73. PubMed ID: 26365710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
    Saxena AK; Alam M
    Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.
    Correa-Basurto J; Bello M; Rosales-Hernández MC; Hernández-Rodríguez M; Nicolás-Vázquez I; Rojo-Domínguez A; Trujillo-Ferrara JG; Miranda R; Flores-Sandoval CA
    Chem Biol Interact; 2014 Feb; 209():1-13. PubMed ID: 24321698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
    Ozpolat B; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding.
    Gomaa MS; Yee SW; Milbourne CE; Barbera MC; Simons C; Brancale A
    J Enzyme Inhib Med Chem; 2006 Aug; 21(4):361-9. PubMed ID: 17059167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and quantitative structure activity relationship (QSAR) of arylidene (benzimidazol-1-yl)acetohydrazones as potential antibacterial agents.
    El-Kilany Y; Nahas NM; Al-Ghamdi MA; Badawy ME; El Ashry el SH
    World J Microbiol Biotechnol; 2015 Jan; 31(1):145-52. PubMed ID: 25304024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates.
    Gomaa MS; Lim AS; Lau SC; Watts AM; Illingworth NA; Bridgens CE; Veal GJ; Redfern CP; Brancale A; Armstrong JL; Simons C
    Bioorg Med Chem; 2012 Oct; 20(20):6080-8. PubMed ID: 22989911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenylamino)phenyl)propyl scaffold.
    Gomaa MS; Bridgens CE; Illingworth NA; Veal GJ; Redfern CP; Brancale A; Armstrong JL; Simons C
    Bioorg Med Chem; 2012 Jul; 20(14):4201-7. PubMed ID: 22727372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring QSAR of melatonin receptor ligand benzofuran derivatives using E-state index.
    Sengupta C; Leonard JT; Roy K
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3435-9. PubMed ID: 15177448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.